Position
Quantbot Technologies LP in Moonlake Immunotherapeutics
Back to the book · All holders of MLTX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $540$13.18 → $18.64
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 6.27K | $82.6K | — | — | — | 0.0% |
| Q1 2026 | 99 | $1.84K | $18.64 | $540 | −$81.3K | 0.0% |